Abstract:The optimal structure design of nanocarriers to inhibit premature release of anticancer drugs from nanocarriers during blood circulation and improve drug release inside tumor cells is still a significant issue for polymer micelles applied to antitumor drug delivery. Herein, in order to balance the contradiction between polymer micellar stability and drug release, dual-sensitive cleavable cross-linkages of benzoic imine conjugated disulfide bonds were introduced into the core of the amphiphilic copolymer micelles to form core-cross-linked micelles. First, biodegradable poly(ethylene glycol)-b-(polycaprolactone-g-poly(methacrylic acid-p-hydroxy benzaldehyde-cystamine)), i.e. mPEG-b-(PCL-g-P(MAA-Hy-Cys)) (PECMHC) copolymers were synthesized and assembled into PECMHC micelles (PECMHC Ms). Then, simply by introducing H2O2 to the PECMHC Ms dispersions to oxidate the thiol groups of cystamine moieties in the core, core-cross-linked PECMHC micelles (cc-PECMHC Ms) ∼100 nm in size were readily obtained in water. In vitro studies of doxorubicin (DOX)-loaded cc-PECMHC Ms show that the cross-linked core impeded the drug release in the physical conditions, owing to the high stability of the micelles against both extensive dilution and salt concentration, while it greatly accelerated DOX release in mildly acidic (pH ∼5.0-6.0) medium with glutathione, owing to the coordination of the pH-sensitive cleaving of benzoic imine bonds and the reduction-sensitive cleaving of disulfide bonds. The in vivo tissue distribution and tumor accumulation of the DOX-loaded cc-PECMHC Ms were monitored via fluorescence images of DOX. DOX-loaded cc-PECMHC Ms exhibited enhanced tumor accumulation because of their high stability in blood circulation and less DOX premature release. Therefore, the cc-PECMHC Ms with dual-sensitive cleavable bonds in the cross-linked core were of excellent biocompatibility, high extracellular stability and had intelligent intracellular drug release properties, indicating promise as candidates for anticancer drug delivery.

Electrospun Micelles/Drug‐Loaded Nanofibers for Time‐Programmed Multi‐Agent Release

Electrospun micelles/drug-loaded nanofibers for time-programmed multi-agent release.

Novel Controlled Drug Delivery System for Multiple Drugs Based on Electrospun Nanofibers Containing Nanomicelles

Controlled Dual Drug Release and in Vitro Cytotoxicity of Electrospun Poly(Lactic-Co-Glycolic Acid) Nanofibers Encapsulated with Micelles

Controlled Release of Multiple Hydrophilic and Hydrophobic Drugs and in vitro Cytotoxicity of Electrospun Poly(lactic-co-glycolic acid)/ZnO Nanofibers Encapsulated with Dual Drugs

A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles.

Electrospun composite nanofibers containing nanoparticles for the programmable release of dual drugs

Electrospinning of Biomacromolecules for Controlled Drug Release

Retracted Article: Preparation and Properties of Polymer Micelle-embedded Nanofibrous Membranes for Dual-drug Co-delivery and Multistep Release

A Time-Programmed Release of Dual Drugs from an Implantable Trilayer Structured Fiber Device for Synergistic Treatment of Breast Cancer.

An Implantable Active-Targeting Micelle-in-nanofiber Device for Efficient and Safe Cancer Therapy.

Balancing the Stability and Drug Release of Polymer Micelles by the Coordination of Dual-Sensitive Cleavable Bonds in Cross-Linked Core.

Fabrication of Core–shell Micro/nanoparticles for Programmable Dual Drug Release by Emulsion Electrospraying

ueous-based dual drug loaded silk fi broin electrospun nano fi bers embedded with curcumin-loaded RSF nanospheres for drugs controlled release †

Synchronized Delivery of Dual-Drugs for Potentiating Combination Chemotherapy Based on Smart Triple-Responsive Polymeric Micelles

Size-controllable Dual Drug-Loaded Silk Fibroin Nanospheres Through a Facile Formation Process

Tri-Layer Core–Shell Fibers from Coaxial Electrospinning for a Modified Release of Metronidazole

Sequential thermo-induced self-gelation and acid-triggered self-release process of drug-conjugated nanoparticles: A strategy for the sustained and controlled drug delivery to tumors

Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment

In Situ DOX-calcium Phosphate Mineralized CPT-amphiphilic Gelatin Nanoparticle for Intracellular Controlled Sequential Release of Multiple Drugs.

Polymer-controlled core–shell nanoparticles: a novel strategy for sequential drug release